These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22365974)

  • 1. MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma.
    Elsner M; Rauser S; Maier S; Schöne C; Balluff B; Meding S; Jung G; Nipp M; Sarioglu H; Maccarrone G; Aichler M; Feuchtinger A; Langer R; Jütting U; Feith M; Küster B; Ueffing M; Zitzelsberger H; Höfler H; Walch A
    J Proteomics; 2012 Aug; 75(15):4693-704. PubMed ID: 22365974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer.
    Meding S; Balluff B; Elsner M; Schöne C; Rauser S; Nitsche U; Maak M; Schäfer A; Hauck SM; Ueffing M; Langer R; Höfler H; Friess H; Rosenberg R; Walch A
    J Pathol; 2012 Dec; 228(4):459-70. PubMed ID: 22430872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging.
    Nipp M; Elsner M; Balluff B; Meding S; Sarioglu H; Ueffing M; Rauser S; Unger K; Höfler H; Walch A; Zitzelsberger H
    J Mol Med (Berl); 2012 Feb; 90(2):163-74. PubMed ID: 21938494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
    Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
    J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis reveals overexpression of moesin and cytokeratin 17 proteins in colorectal carcinoma.
    Kim CY; Jung WY; Lee HJ; Kim HK; Kim A; Shin BK
    Oncol Rep; 2012 Mar; 27(3):608-20. PubMed ID: 22076435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker.
    Lemaire R; Menguellet SA; Stauber J; Marchaudon V; Lucot JP; Collinet P; Farine MO; Vinatier D; Day R; Ducoroy P; Salzet M; Fournier I
    J Proteome Res; 2007 Nov; 6(11):4127-34. PubMed ID: 17939699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
    Yacoub L; Goldman H; Odze RD
    Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria.
    Aichler M; Elsner M; Ludyga N; Feuchtinger A; Zangen V; Maier SK; Balluff B; Schöne C; Hierber L; Braselmann H; Meding S; Rauser S; Zischka H; Aubele M; Schmitt M; Feith M; Hauck SM; Ueffing M; Langer R; Kuster B; Zitzelsberger H; Höfler H; Walch AK
    J Pathol; 2013 Aug; 230(4):410-9. PubMed ID: 23592244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas.
    Regalado SP; Nambu Y; Iannettoni MD; Orringer MB; Beer DG
    Mol Carcinog; 1998 Jul; 22(3):182-9. PubMed ID: 9688144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coamplification and coexpression of GRB7 and ERBB2 is found in high grade intraepithelial neoplasia and in invasive Barrett's carcinoma.
    Walch A; Specht K; Braselmann H; Stein H; Siewert JR; Hopt U; Höfler H; Werner M
    Int J Cancer; 2004 Dec; 112(5):747-53. PubMed ID: 15386389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma.
    Rauser S; Langer R; Tschernitz S; Gais P; Jütting U; Feith M; Höfler H; Walch A
    BMC Cancer; 2010 Nov; 10():608. PubMed ID: 21054833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Tissue Proteomics of Microdissected Specimens Reveals Novel Candidate Biomarkers of Bladder Cancer.
    Chen CL; Chung T; Wu CC; Ng KF; Yu JS; Tsai CH; Chang YS; Liang Y; Tsui KH; Chen YT
    Mol Cell Proteomics; 2015 Sep; 14(9):2466-78. PubMed ID: 26081836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of mitochondrial energy metabolism profiles across the metaplasia-dysplasia-adenocarcinoma disease sequence in Barrett's oesophagus.
    Phelan JJ; MacCarthy F; Feighery R; O'Farrell NJ; Lynam-Lennon N; Doyle B; O'Toole D; Ravi N; Reynolds JV; O'Sullivan J
    Cancer Lett; 2014 Nov; 354(1):122-31. PubMed ID: 25107643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of matrix coating assisted by an electric field (MCAEF) to enhance mass spectrometric imaging of human prostate cancer biomarkers.
    Wang X; Han J; Hardie DB; Yang J; Borchers CH
    J Mass Spectrom; 2016 Jan; 51(1):86-95. PubMed ID: 26757076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression profiling of human pancreatic adenocarcinoma and healthy pancreatic tissue.
    Lu Z; Hu L; Evers S; Chen J; Shen Y
    Proteomics; 2004 Dec; 4(12):3975-88. PubMed ID: 15526344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma.
    Dekker TJ; Balluff BD; Jones EA; Schöne CD; Schmitt M; Aubele M; Kroep JR; Smit VT; Tollenaar RA; Mesker WE; Walch A; McDonnell LA
    J Proteome Res; 2014 Nov; 13(11):4730-8. PubMed ID: 24762205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry.
    Rauser S; Marquardt C; Balluff B; Deininger SO; Albers C; Belau E; Hartmer R; Suckau D; Specht K; Ebert MP; Schmitt M; Aubele M; Höfler H; Walch A
    J Proteome Res; 2010 Apr; 9(4):1854-63. PubMed ID: 20170166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.
    Brabender J; Marjoram P; Salonga D; Metzger R; Schneider PM; Park JM; Schneider S; Hölscher AH; Yin J; Meltzer SJ; Danenberg KD; Danenberg PV; Lord RV
    Oncogene; 2004 Jun; 23(27):4780-8. PubMed ID: 15107828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma.
    Helm J; Enkemann SA; Coppola D; Barthel JS; Kelley ST; Yeatman TJ
    Clin Cancer Res; 2005 Apr; 11(7):2478-85. PubMed ID: 15814623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.